Michael Geschwind
#48,235
Most Influential Person Now
Researcher
Michael Geschwind's AcademicInfluence.com Rankings
Michael Geschwindbiology Degrees
Biology
#9392
World Rank
#12593
Historical Rank
Neuroscience
#2631
World Rank
#2701
Historical Rank
Michael Geschwindphilosophy Degrees
Philosophy
#10996
World Rank
#15099
Historical Rank
Logic
#7819
World Rank
#9710
Historical Rank
Download Badge
Biology Philosophy
Michael Geschwind's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Neuroscience University of California, San Francisco
Why Is Michael Geschwind Influential?
(Suggest an Edit or Addition)According to Wikipedia, Michael D. Geschwind is a professor of neurology at the UCSF Memory and Aging Center , specializing in neurodegenerative disorders. Geschwind has published highly-cited papers on rapidly progressive dementias, prion diseases , Alzheimer disease, and limbic and autoimmune encephalitis. He has served as the principal investigator on studies on human prion disease and Creutzfeldt-Jacob disease. He was guest editor for the American Academy of Neurology Continuum Dementia edition, and was on the AAN committee for dementia criteria. He has also published highly-cited papers on cognitive dysfunction in movement disorders, and serves as the director of the MAC Huntington's Disease center.
Michael Geschwind's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A clinical approach to diagnosis of autoimmune encephalitis (2016) (2278)
- AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location (2009) (708)
- Seizures and epileptiform activity in the early stages of Alzheimer disease. (2013) (493)
- Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. (2018) (454)
- Clinicopathological correlations in corticobasal degeneration (2011) (351)
- Regulated Release and Polarized Localization of Brain-Derived Neurotrophic Factor in Hippocampal Neurons (1996) (344)
- Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. (2005) (332)
- Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias (2011) (318)
- Rapidly progressive dementia (2008) (315)
- Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. (1995) (296)
- Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. (2006) (295)
- Diagnosis of human prion disease. (2005) (277)
- The importance of early immunotherapy in patients with faciobrachial dystonic seizures (2017) (222)
- Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. (2012) (208)
- Variably protease‐sensitive prionopathy: A new sporadic disease of the prion protein (2010) (207)
- Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. (1992) (197)
- Encephalitis and AMPA receptor antibodies (2015) (180)
- Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. (2008) (173)
- Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. (2003) (149)
- First symptom in sporadic Creutzfeldt–Jakob disease (2006) (135)
- Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy. (2014) (124)
- Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects. (2012) (120)
- Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series (2008) (111)
- Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease (2013) (110)
- Defective HSV-1 vector expressing BDNF in auditory ganglia elicits neurite outgrowth: model for treatment of neuron loss following cochlear degeneration. (1996) (103)
- Rapidly Progressive Dementia (2007) (102)
- Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease (2021) (96)
- Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study (2013) (94)
- Presenile dementia syndromes: an update on taxonomy and diagnosis (2002) (93)
- Exome sequencing identifies ACSF3 as the cause of Combined Malonic and Methylmalonic Aciduria (2011) (90)
- Distinct HLA associations of LGI1 and CASPR2-antibody diseases (2018) (87)
- A randomized, placebo-controlled trial of latrepirdine in Huntington disease. (2010) (86)
- The diagnostic utility of brain biopsy procedures in patients with rapidly deteriorating neurological conditions or dementia. (2007) (84)
- Differential diagnosis of Jakob-Creutzfeldt disease. (2012) (79)
- Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature (2017) (78)
- Depression and clinical progression in spinocerebellar ataxias. (2016) (75)
- Refining the diagnosis of Huntington disease: the PREDICT-HD study (2013) (71)
- Diagnosis and treatment of rapidly progressive dementias (2012) (70)
- Adult‐onset drug‐refractory seizure disorder associated with anti–voltage‐gated potassium‐channel antibody (2010) (70)
- Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study. (2008) (67)
- An Epigenetic Signature in Peripheral Blood Associated with the Haplotype on 17q21.31, a Risk Factor for Neurodegenerative Tauopathy (2014) (66)
- Correlating DWI MRI With Pathologic and Other Features of Jakob-Creutzfeldt Disease (2009) (64)
- Genetic PrP Prion Diseases. (2018) (64)
- Transfer of the nerve growth factor gene into cell lines and cultured neurons using a defective herpes simplex virus vector. Transfer of the NGF gene into cells by a HSV-1 vector. (1994) (61)
- Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease (2007) (58)
- Executive functions in premanifest Huntington's disease (2014) (58)
- Association of Blood and Cerebrospinal Fluid Tau Level and Other Biomarkers With Survival Time in Sporadic Creutzfeldt-Jakob Disease. (2019) (54)
- The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS (2011) (54)
- Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease (2015) (52)
- A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease. (2013) (49)
- Human prions and plasma lipoproteins. (2006) (47)
- Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis. (2014) (47)
- Prion disease. (2018) (47)
- White matter involvement in sporadic Creutzfeldt-Jakob disease (2014) (46)
- A diagnostic ceiling for exome sequencing in cerebellar ataxia and related neurological disorders (2020) (42)
- Sporadic Creutzfeldt-Jakob disease mimicking variant Creutzfeldt-Jakob disease. (2003) (42)
- HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD) (2016) (41)
- Ascertainment bias causes false signal of anticipation in genetic prion disease. (2014) (41)
- RAPIDLY PROGRESSIVE DEMENTIA: PRION DISEASES AND OTHER RAPID DEMENTIAS (2010) (41)
- Neurodegenerative Disease Phenotypes in Carriers of MAPT p.A152T, A Risk Factor for Frontotemporal Dementia Spectrum Disorders and Alzheimer Disease (2013) (41)
- Prion Seeds Distribute throughout the Eyes of Sporadic Creutzfeldt-Jakob Disease Patients (2018) (40)
- Glucose metabolism in sporadic Creutzfeldt–Jakob disease: a statistical parametric mapping analysis of 18F‐FDG PET (2012) (40)
- Creutzfeldt-Jakob Disease in Recipients of Corneal Transplants (2008) (39)
- Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt–Jakob disease (2007) (39)
- Age at onset in genetic prion disease and the design of preventive clinical trials (2019) (39)
- Application of quantitative DTI metrics in sporadic CJD (2014) (39)
- Prion Disease Induces Alzheimer Disease–Like Neuropathologic Changes (2015) (38)
- Dystonia and ataxia progression in spinocerebellar ataxias. (2017) (37)
- The Initial Symptom and Motor Progression in Spinocerebellar Ataxias (2017) (35)
- Prion Diseases (2013) (34)
- A 54-year-old man with slowness of movement and confusion (2007) (34)
- Coenzyme Q10 and spinocerebellar ataxias (2015) (34)
- Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development (2019) (34)
- Neuroimaging in dementia. (2008) (33)
- Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging. (2006) (32)
- Prion Diseases (2015) (32)
- Immunologically mediated dementias (2009) (31)
- Differential diagnosis with other rapid progressive dementias in human prion diseases. (2018) (31)
- Neuroimaging in Dementia (2010) (30)
- Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study (2020) (29)
- Prion Diseases. (2018) (29)
- MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations (2016) (29)
- Clinical update of Jakob-Creutzfeldt disease. (2015) (28)
- Autoimmune Encephalopathies (2007) (28)
- Prion proteins in subpopulations of white blood cells from patients with sporadic Creutzfeldt-Jakob disease (2009) (28)
- Age of onset in genetic prion disease and the design of preventive clinical trials (2018) (27)
- Ethics in prion disease (2013) (27)
- Clinical trials for prion disease: difficult challenges, but hope for the future (2009) (26)
- Genetic CJD with a novel E200G mutation in the prion protein gene and comparison with E200K mutation cases (2013) (26)
- Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone (2015) (25)
- Familial Creutzfeldt-Jakob Disease with V180I Mutation (2010) (24)
- Localized gene transfer into organotypic hippocampal slice cultures and acute hippocampal slices (1993) (24)
- Dementia assessment and management in primary care settings: a survey of current provider practices in the United States (2019) (24)
- More than memory impairment in voltage‐gated potassium channel complex encephalopathy (2014) (24)
- Sporadic Jakob-Creutzfeldt disease presenting as primary progressive aphasia. (2012) (24)
- When sporadic disease is not sporadic: the potential for genetic etiology. (2004) (24)
- Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias (2017) (23)
- Clinical Overlap between Jakob-Creutzfeldt Disease and Lewy Body Disease (2012) (22)
- A case of enteroviral meningoencephalitis presenting as rapidly progressive dementia (2008) (22)
- Clinico-pathological correlation in adenylate kinase 5 autoimmune limbic encephalitis (2015) (21)
- Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases (2018) (20)
- Ring trial of 2nd generation RT‐QuIC diagnostic tests for sporadic CJD (2020) (18)
- GABAA receptor autoimmunity (2019) (18)
- Modulation of Creutzfeldt‐Jakob disease prion propagation by the A224V mutation (2015) (18)
- NEUROIMAGING IN DEMENTIA (2010) (17)
- Rapidly Progressive Dementia. (2016) (17)
- Metabolic disorders with clinical and radiologic features of sporadic Creutzfeldt-Jakob disease. (2015) (16)
- Intrathecal B-cell activation in LGI1 antibody encephalitis (2020) (15)
- Deutetrabenazine for Treatment of Chorea in Huntington Disease. (2016) (15)
- Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy. (2016) (15)
- Prion disease: Thorough work-up and new diagnostic criteria needed for CJD (2011) (15)
- Seizure-related 6 homolog like 2 autoimmunity (2020) (14)
- Expression of Neurotrophic Genes from Herpes Simplex Virus Type 1 Vectors: Modifying Neuronal Phenotype (1994) (14)
- Tremor in the Degenerative Cerebellum: Towards the Understanding of Brain Circuitry for Tremor (2019) (14)
- Latent NOTCH3 epitopes unmasked in CADASIL and regulated by protein redox state (2014) (14)
- Quantitative 7T Phase Imaging in Premanifest Huntington Disease (2014) (13)
- Anti-gamma-aminobutyric acid receptor type A encephalitis: a review. (2020) (13)
- Egocentric and allocentric visuospatial working memory in premotor Huntington's disease: A double dissociation with caudate and hippocampal volumes (2017) (13)
- Preimplantation genetic diagnosis (PGD) for genetic prion disorder due to F198S mutation in the PRNP gene. (2014) (13)
- Expanding the global prevalence of spinocerebellar ataxia type 42 (2018) (13)
- An Opioid-Related Amnestic Syndrome With Persistent Effects on Hippocampal Structure and Function. (2019) (13)
- Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease (2015) (12)
- Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions (2019) (12)
- Pathologic Evidence That the T188R Mutation in PRNP Is Associated With Prion Disease (2010) (12)
- The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3. (2020) (11)
- Neurodegeneration as the presenting symptom in 2 adults with xeroderma pigmentosum complementation group F (2018) (10)
- Autoimmune Encephalitis Misdiagnosis in Adults (2022) (10)
- Creutzfeldt–Jakob Disease–Like Periodic Sharp Wave Complexes in Voltage-Gated Potassium Channel–Complex Antibodies Encephalitis: A Case Report (2016) (9)
- Multimodal MRI staging for tracking progression and clinical-imaging correlation in sporadic Creutzfeldt-Jakob disease (2020) (9)
- The active intrathecal B-cell response in LGI1-antibody encephalitis (2015) (9)
- Psychiatric and neuroimaging findings in Creutzfeldt-Jakob disease (2003) (9)
- Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy (2022) (9)
- Surface-based morphometry reveals caudate subnuclear structural damage in patients with premotor Huntington disease (2017) (9)
- Autoimmune-Mediated Encephalopathy: Classification, Evaluation, and MR Imaging Patterns of Disease (2011) (8)
- A case cluster of variant Creutzfeldt-Jakob disease linked to the Kingdom of Saudi Arabia. (2016) (7)
- Whipple's disease masquerades as dementia with Lewy bodies. (2015) (7)
- Vascular Risk Factors and Clinical Progression in Spinocerebellar Ataxias (2015) (6)
- Doxycycline for Creutzfeldt-Jakob disease: a failure, but a step in the right direction (2014) (6)
- Prion protein quantification in cerebrospinal fluid as a tool for prion disease drug development (2018) (5)
- Human Leukocyte Antigen Association Study Reveals DRB1*04:02 Effects Additional to DRB1*07:01 in Anti-LGI1 Encephalitis (2022) (5)
- De novo prions (2010) (4)
- Cerebellar top-of-the-basilar syndrome (1998) (4)
- Development of a Diagnostic Decision Tree for Rapidly Progressive Dementia (P5.182) (2016) (3)
- New Sensitive Measures of Executive Functioning in Premotor Huntington's Disease (S20.002) (2013) (3)
- C9orf72 repeat expansions as genetic modifiers for depression in spinocerebellar ataxias (2018) (3)
- Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases (2022) (3)
- Selective vulnerability to atrophy in sporadic Creutzfeldt‐Jakob disease (2021) (3)
- Neuropsychological Profiles Of Voltage-Gated Potassium Channel Complex And Other Autoimmune Encephalopathies; More Than Memory Impairment (S18.005) (2014) (2)
- Clinically meaningful MR endpoints sensitive to preataxic SCA1 and SCA3 (2022) (2)
- Baseline neuropsychological profiles in prion disease predict survival time (2020) (2)
- The Behavioral Neurology of Dementia: Prion disorders and other rapidly progressive dementias (2009) (2)
- Genome-wide association study identifies risk variants for sporadic Creutzfeldt-Jakob disease in STX6 and GAL3ST1 (2020) (2)
- Infections of the Nervous System (2012) (2)
- CSF Biomarkers Findings in a Large Rapidly Progressive Dementia Cohort (S14.004) (2012) (2)
- Dysphagia in spinocerebellar ataxias type 1, 2, 3 and 6 (2020) (2)
- Default Mode Network quantitative diffusion and resting‐state functional magnetic resonance imaging correlates in sporadic Creutzfeldt‐Jakob disease (2022) (2)
- Developing neuropalliative care for sporadic Creutzfeldt-Jakob Disease (2022) (2)
- Genetic CJD with a novel E200G mutation in the prion protein gene and comparison with E200K mutation cases (2013) (1)
- P3-378 Evaluation of the efficacy of quinacrine in animal models of prion disease (2004) (1)
- Autoimmune antibody-associated encephalopathy and dementia syndromes (2016) (1)
- Prions induce an early Arc response and a subsequent reduction in mGluR5 in the hippocampus (2022) (1)
- Early cortical and late striatal diffusion restriction on 3T MRI in a long‐lived sporadic creutzfeldt–jakob disease case (2019) (1)
- White Matter Disorders (2016) (1)
- The S-Factor, a New Measure of Disease Severity in Spinocerebellar Ataxia: Findings and Implications. (2022) (1)
- Autoimmune Encephalitis Misdiagnosis in Adults; A Multicenter Observational Study of Outpatient Subspecialty Clinics (2022) (1)
- Preimplantation Genetic Diagnosis for a Genetic Prion Disease (2014) (1)
- Transmissible Spongiform Encephalopathies (2007) (1)
- Bradycardia Leading To Pacemaker Placement: A Characteristic Prodromal Syndrome Of VGKCC/LGI1 Antibody Associated Encephalitis (P5.195) (2014) (1)
- Ethical Issues in Human Prion Diseases from a Major Referral Center (P02.007) (2013) (1)
- Dementia (2016) (1)
- Comprar Non-Alzheimer's Dementia | Michael D. Geschwind | 9781444336245 | Wiley (2016) (0)
- Neuropsychiatric Features of Parkinsonism Dementia Complex and Other Neurodegenerative Diseases on Guam (P05.040) (2012) (0)
- A Novel POLR1C Mutation Causing Autosomal Recessive Adult-Onset Leukodystrophy (P5.171) (2016) (0)
- Development of an Expert Consensus Approach to Screening, Assessment, and Diagnosis of Patients at Risk for Neurodegenerative Disease (S1.006) (2016) (0)
- Mass Confusion. (2017) (0)
- Bilateral basal ganglia infarcts presenting as rapid onset cognitive and behavioral disturbance (2020) (0)
- Diminished neuronal ESCRT-0 function exacerbates AMPA receptor derangement and accelerates prion-induced neurodegeneration. (2023) (0)
- Genetic prion disease caused by a Q160X PRNP mutation presenting with an orbitofrontal syndrome (P4.100) (2015) (0)
- Creutzfeldt–Jakob Disease (CJD) (2014) (0)
- Limbic encephalitis with antibodies to LGI1 is associated with an active intrathecal B cell response (2014) (0)
- Determining Etiologic Diagnoses in Patients with Rapidly Progressive Dementia (2022) (0)
- J05 Interim results from cohort 1 of the double-blind, dose-escalation phase I/II clinical trial of amt-130 (HD-genetrx-1) for early-stage huntington’s disease (HD) (2022) (0)
- The multidisciplinary evaluation of the atypical dementia patient (2016) (0)
- Genetic modification of rat RPE cells using herpes and adenoviral vectors (1996) (0)
- Neuroimaging of prion diseases (2015) (0)
- 48 – Prion Diseases (2012) (0)
- Coenzyme Q10, Statin, and Spinocerebellar Ataxias (P6.047) (2014) (0)
- Changes in wall thickness of retinal arterioles as a surrogate marker of intracranial vascular pathology (2021) (0)
- Clinical impact of C9orf72 repeat expansion in Spinocerebellar Ataxias (P2.128) (2015) (0)
- Retinal arteriolar parameters as a surrogate marker of intracranial vascular pathology (2022) (0)
- Retinal Prion Protein Deposition in Sporadic Creutzfeld-Jakob Disease: A Retrospective Study of 14 Cases (2018) (0)
- Amyloid Imaging in AD , MCI , DLB , PDD , PD , and FTD using 11 CPIB PET (0)
- Cognitive Impairment and the Dementias (2014) (0)
- Neurocase, Volume 21, Guest reviewers (2015) (0)
- Contributors to Volume 21 (1994) (0)
- Chronic Fatigue Syndrome (2003) (0)
- Cognitive Deficits Related to HCV, HIV, and Methamphetamines (2005) (0)
- Treatable Dementias Mistaken for CJD (2011) (0)
- Caregiver Experiences Navigating the Diagnostic Journey in a Rapidly Progressing Dementia. (2022) (0)
- Surface-based morphometry reveals caudate subnuclear structural damage in patients with premotor Huntington disease (2016) (0)
- Prion Deposition in the Retina of Sporadic Cruetzfeldt‐Jakob Disease (2018) (0)
- The Initial Clinical Presentation of Spinocerebellar Ataxias Type 1, 2, 3, and 6 (P6.393) (2016) (0)
- P.006 Etiologic diagnoses of rapidly progressive dementia in a prospective multicenter cohort (2022) (0)
- Cortical and Subcortical Atrophy and Diffusion Restriction in SCJD (P05.036) (2012) (0)
- Clinical Features and Pathogenesis of Prion Disease (2013) (0)
- Jakob–Creutzfeldt disease and other prion diseases (2017) (0)
- Prion diseases and rapidly progressive dementias (2016) (0)
- Causes of Rapidly Progressive Dementia in a Prospectively Accrued Cohort (P2-6.009) (2023) (0)
- Improving Early Recognition of Potentially Treatable Causes of Rapidly Progressive Dementia (P5-12.001) (2023) (0)
- Comparison of quantitative susceptibility mapping methods for iron-sensitive susceptibility imaging at 7T: An evaluation in healthy subjects and patients with Huntington's disease (2022) (0)
- Restricted Diffusion in White Matter of Sporadic Jakob-Creutzfeldt Disease (P06.044) (2013) (0)
- The Initial Symptom and Motor Progression in Spinocerebellar Ataxias (2016) (0)
- PRNP expression predicts imaging findings in sporadic Creutzfeldt‐Jakob disease (2023) (0)
- Wernicke-Korsakoff Syndrome Mimicking Sporadic Jakob-Creutzfeldt Disease (P5.235) (2014) (0)
- Volumetric Quantification of Neurodegeneration Shows Selective Vulnerability of the Default-Mode Network in Sporadic Creutzfeldt-Jakob Disease (P4.035) (2016) (0)
- Reasons for early immunotherapy in 103 patients with faciobrachial dystonic seizures: Effect on short and long-term outcomes (2017) (0)
- Clinico-pathological correlation in adenylate kinase 5 autoimmune limbic encephalitis Journal of Neuroimmunology (2015) (0)
- Biomarker-based diagnosis of sporadic Creutzfeldt-Jakob disease (2021) (0)
- Precipitous Deterioration of Motor Function, Cognition, and Behavior (2017) (0)
- CSF Total and Phosphorylated Tau Biomarker Findings in a Large Rapidly Progressive Dementia Cohort (P03.077) (2013) (0)
- PreimplantationGeneticDiagnosis(PGD)forGeneticPrion DisorderDuetoF198SMutationinthePRNPGene (2014) (0)
- Executive and Motor Impairment Correlation in SCA-3 (P2.131) (2015) (0)
- 122. Voltage-gated Potassium Channel Autoimmunity Mimicking Creutzfeldt-Jakob Disease (2009) (0)
- Non-Alzheimer's and Atypical Dementia: Geschwind/Non-Alzheimer's and Atypical Dementia (2016) (0)
- Strategies to Support Surrogate DecisionMakers of PatientsWith Chronic Critical Illness The Search Continues (2016) (0)
- Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases (2018) (0)
- Coenzyme Q10, Statin, and Spinocerebellar Ataxias (I11-1.008) (2014) (0)
- Quantitative 7 T Phase Imaging in Presymptomatic Huntington ’ s Disease (2011) (0)
- The spectrum of human prion diseases (2017) (0)
- Report on cluster of three autopsy confirmed cases of sporadic Creutzfeldt–/INS;Jakob disease from Luxembourg including videos, imaging, genetics and neuropathology (2013) (0)
- Hetereogeneity of Neurodegenerative Diseases on Guam (P05.037) (2012) (0)
- Tremor in the Degenerative Cerebellum: Towards the Understanding of Brain Circuitry for Tremor (2019) (0)
- Contributors (2012) (0)
- Kuru Susceptibility Genetics (2010) (0)
- Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone (2015) (0)
- Are you Related to “the Geschwind?” (2010) (0)
- Expression of nerve growth factor in vivo from a defective herpes (2004) (0)
This paper list is powered by the following services:
Other Resources About Michael Geschwind
What Schools Are Affiliated With Michael Geschwind?
Michael Geschwind is affiliated with the following schools:
